A Prospective Clinical Study of Recombinant Anti-CD25 Humanized Monoclonal Antibody for the Prevention of Graft-versus-Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplantation

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 9d5f4fb841fdecfdf5a53c7d4b7a8c082c111279
First added on: Oct 10, 2026